Spasticity is a neurologic disorder in children that can interfere with development, function,
and participation caused by a variety of processes affecting the central nervous system. 1 In …

Hidradenitis suppurativa (HS) is a painful, inflammatory skin disease that has historically
been understudied in the pediatric population. Procedural interventions, such as surgical …

Cerebral Palsy (CP) is the most frequent cause of childhood disability. CP occurs in 1 out of
every 345 children in the United States. CP is primarily a motor disease that is the result of …

Neurological morbidity is common after pediatric stroke, with moderate to severe deficits that
can significantly impact education and social function. Care and recovery occur in phases …

Botulinum toxin type A1 is a first-line treatment for adult and pediatric spasticity. However,
when considering the quantity of 150 kDa neurotoxin protein in relation to patient weight and …

Current Opinion in Otolaryngology & Head and Neck Surgery Log in or Register Subscribe
to journalSubscribe Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced …

Baclofen is often considered a first-line treatment option for spasticity management in
children. However, adverse effects, administration, and dosing can be barriers to …

Aim To identify the incidence and type of adverse events reported after chemodenervation
with onabotulinum neurotoxin A (BoNT‐A) in children with hypertonia and sialorrhea and …

Abstract Background Botulinum toxin (BoNT) causes sarcopenia and low bone mass in
animal studies. Whether such effect exists in children and adolescents with spastic cerebral …

Botulinum toxin has been increasingly studied and used for varying conditions, most
notably, cosmetics. However, it has been shown that botulinum toxin demonstrates a high …